ClearBridge Investments
VYGR icon

ClearBridge Investments’s Voyager Therapeutics VYGR Stock Holding History

ClearBridge Investments’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,383,414
Closed -$6.52M – 854
2021
Q1 		$6.52M Sell
1,383,414
-3,251
-0.2% -$22.2K ﹤0.01% 577
2020
Q4 		$9.91M Buy
1,386,665
+253
+0% +$2.43K 0.01% 553
2020
Q3 		$14.8M Buy
1,386,412
+8,101
+0.6% +$95.1K 0.01% 479
2020
Q2 		$17.4M Buy
1,378,311
+169,636
+14% +$1.97M 0.02% 429
2020
Q1 		$11.1M Buy
1,208,675
+196,342
+19% +$2.25M 0.01% 464
2019
Q4 		$13.7M Sell
1,012,333
-226,628
-18% -$3.29M 0.01% 510
2019
Q3 		$21.3M Buy
1,238,961
+859,988
+227% +$18.1M 0.02% 415
2019
Q2 		$10.3M Sell
378,973
-1,000
-0.3% -$22.9K 0.01% 528
2019
Q1 		$7.27M Buy
379,973
+379,565
+93,031% +$4.94M 0.01% 553
2018
Q4 		$4K Hold
408
– – ﹤0.01% 1076
2018
Q3 		$8K Hold
408
– – ﹤0.01% 1068
2018
Q2 		$8K Sell
408
-67,092
-99% -$1.33M ﹤0.01% 1036
2018
Q1 		$1.27M Sell
67,500
-546
-0.8% -$11.8K ﹤0.01% 620
2017
Q4 		$1.13M Buy
68,046
+65,993
+3,214% +$1.13M ﹤0.01% 631
2017
Q3 		$42K Buy
+2,053
New +$23.2K ﹤0.01% 873

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ClearBridge Investments's VYGR Position: Q2 2021 in Review

ClearBridge Investments sold out of Voyager Therapeutics (VYGR) in Q2 2021, closing a stake of 1,383,414 shares — an estimated $6.52M sold.

ClearBridge Investments first reported a position in VYGR in Q3 2017 and held it in 15 quarters. The position peaked at $21.3M in Q3 2019. 78 funds tracked by Wall St. Rank hold VYGR as of Q2 2021.

  • ClearBridge Investments reported no remaining Voyager Therapeutics position as of Q2 2021 after selling out during the quarter.
  • ClearBridge Investments sold 1,383,414 Voyager Therapeutics shares in Q2 2021, an estimated $6.52M.
  • ClearBridge Investments first reported a position in Voyager Therapeutics in Q3 2017 and held it in 15 quarters.
  • ClearBridge Investments's Voyager Therapeutics position peaked at $21.3M in Q3 2019.
  • 78 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2021.

Based on ClearBridge Investments's 13F filing for Q2 2021, filed 13 Aug 2021.